Literature DB >> 3307431

Effects of alterations of zinc-to-phosphorus ratios and meconium content on group B Streptococcus growth in human amniotic fluid in vitro.

I A Hoskins, V G Hemming, T R Johnson, C A Winkel.   

Abstract

Several authors have described the bacterial growth-altering properties of amniotic fluid. We examined Group B Streptococcus growth in aseptically obtained amniotic fluid in vitro after altering its zinc, phosphorus, and meconium contents. Zinc and phosphorus levels were calculated in amniotic fluid and in meconium. Separate solutions of zinc and phosphorus were added to yield concentrations of 0.7, 7.0, 70, and 700 mumol. The solutions were incubated with Group B Streptococcus III 893 and Escherichia coli C5 strains, and 24-hour growth curves were plotted. Meconium, 0.5 mg/ml, was added to each amniotic fluid + zinc and amniotic fluid + phosphorus solution, and growth curves were plotted. The rate of proliferation of Group B Streptococcus varied directly with the zinc concentration (700 = 70 greater than 7 greater than 0.7 mumol) and inversely with the phosphorus content (700 less than 70 less than 7 = 0.7 mumol). Meconium enhanced the proliferative effect of zinc and hindered the inhibitory effect of phosphorus. Thus one possible mechanism whereby meconium enhances bacterial growth in amniotic fluid may be by alteration of zinc-to-phosphorus ratios.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3307431     DOI: 10.1016/s0002-9378(87)80047-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  Bacteria and endotoxin in meconium-stained amniotic fluid at term: could intra-amniotic infection cause meconium passage?

Authors:  Roberto Romero; Bo Hyun Yoon; Piya Chaemsaithong; Josef Cortez; Chan-Wook Park; Rogelio Gonzalez; Ernesto Behnke; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo
Journal:  J Matern Fetal Neonatal Med       Date:  2013-12-16

Review 2.  Antibiotics for meconium-stained amniotic fluid in labour for preventing maternal and neonatal infections.

Authors:  Thitiporn Siriwachirachai; Ussanee S Sangkomkamhang; Pisake Lumbiganon; Malinee Laopaiboon
Journal:  Cochrane Database Syst Rev       Date:  2014-11-06

3.  Prophylactic cefazolin in amnioinfusions administered for meconium-stained amniotic fluid.

Authors:  R K Edwards; P Duff
Journal:  Infect Dis Obstet Gynecol       Date:  1999

4.  Bacterial growth in amniotic fluid is dependent on the iron-availability and the activity of bacterial iron-uptake system.

Authors:  Young-Joon Ahn; Sang-Kee Park; Jae-Wook Oh; Hui Yu Sun; Sung-Heui Shin
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

5.  The utility of amnioinfusion in the prophylaxis of meconium-stained amniotic fluid infectious morbidity.

Authors:  C D Adair; J W Weeks; G Johnson; S Burlison; S London; D F Lewis
Journal:  Infect Dis Obstet Gynecol       Date:  1997

6.  Incidence of chorioamnionitis in patients with meconium-stained amniotic fluid.

Authors:  S Chapman; P Duff
Journal:  Infect Dis Obstet Gynecol       Date:  1995

7.  Meconium in the amniotic fluid of pregnancies complicated by preterm premature rupture of membranes is associated with early onset neonatal sepsis.

Authors:  M J Kupferminc; E Wickstrom; N H Cho; P M Garcia
Journal:  Infect Dis Obstet Gynecol       Date:  1995
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.